13F

Stock

Crispr Therapeutics Ag

CRSP · held by 3 managers

Reported value

$19.2M

Holders

3

+0 new · −0 exited

Holders’ est. mark

$1.57M

Price effect on 3 books still in the name

Largest holder

$17.5M

BARCLAYS PLC

Holder count by quarter

Who holds it

Notable only
InvestorSharesValueEst. markChange
BARCLAYS PLC256.3K$17.5M$1.43MCut−$2.12M
Marex Group plc13.1K$892.9K$72.7KAdded$74.9K
Norris Financial Group, LLC12.6K$856K$69.8KCut−$74.7K

Positions as of Q1 2024. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.